Funding for this research was provided by:
Public Health Agency of Canada (PSO-PHAC-2015-1.0313-R10)
Text and Data Mining valid from 2019-01-19
Received: 19 June 2018
Accepted: 25 December 2018
First Online: 19 January 2019
Ethics approval and consent to participate
: Not applicable.
: Written informed consent to publish was obtained from the stakeholders who provided feedback on the protocol. A copy of the written consent is available for review by the Editors-in-Chief of this journal. The stakeholder feedback has been anonymized and included as Additional file InternalRef removed.
: DM is co-editor-in-chief, <i>Systematic Reviews</i>. BH has received consultancy fees from Cornerstone Research Group for methodologic advice related to systematic reviews and meta-analysis and is a member of the Editorial team for <i>Systematic Reviews</i>. SG has received personal fees from UpToDate, personal fees from Eli Lilly, personal fees from Psychotherapy to go, personal fees from Compendium of pharmaceuticals over the last year, outside the submitted work. SP was a co-investigator on a grant supported jointly by the University of Calgary Hotchkiss Brain Institute and Pfizer. BT has received funding from the Canadian Institutes of Health Research to conduct systematic reviews and meta-analyses on the effectiveness of depression screening and the accuracy of depression screening tools. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.